I’ve worked for pharma manufacturers for a long time - you’re right that tablets can be really expensive, but that’s usually driven by the high cost of the active ingredients. Especially if they’re for smaller or (hopefully) acute patient populations like oncology. But generally the actual manufacture of tablets is…